INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/20/2026
Back to search
Official data from USPTO
LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
02/21/2026
Trademark type
Combined
Nice classes
5, 16, 41, 42
Filing date
04/07/2017
Registration date
12/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2025
Last transaction
02/21/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
CH
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "LIMMATECH" above the wording "BIOLOGICS"; there is a curved line design going through the "T" in "LIMMATECH", with three dots at the end of the curved line; at the bottom is the wording "BETTER TECHNOLOGY FOR BETTER HEALTH" with a line on each side of the wording.
Holders and representatives
Holders
LIMMATECH BIOLOGICS AG
Representatives
Christina L. Martini, Esq. DLA Piper LLP (US)
Technical classification
Nice Classes
Class 5Class 16Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of any disease or conditions to be treated by means of therapeutics and vaccinescancerautoimmuneinflammatorybacterial and viral diseases; all the aforesaid goods of Swiss origin
Class 16
Packagingblister packs; packagesboxes of cardboard and paper; promotional material in the nature of advertising postersinstructional sheets in the field of pharmaceuticalsinformation material in the nature of pharmaceutical information leaflets; papercardboardprinted teaching materials in the field of pharmaceuticals; printed productsleaflets for pharmaceutical productspamphlets in the field of pharmaceuticalsmanuals in the field of pharmaceuticalsleaflets about pharmaceutical preparations for the treatment of disorders to be treated by means of therapeutics and vaccinespostersprospectuses featuring information concerning company business in the nature of pharmaceutical productsnewsletters about company business in the nature of pharmaceutical productsdocument files; photographs; graphic representations; business cards; all the aforesaid goods are of Swiss origin
Class 41
Training courses related to research and development of pharmaceuticals; organizing conferences in the field of education for non-business and/or non-commercial purposes; arranging and conducting educational conferences in the field of pharmaceuticals; arranging of seminars; organizing educational conferences in the field of teaching; organization of in-person educationalforum in the field of pharmaceuticals; organization of educational seminarsorganizing conferences in the field of education; organizing conferences in the field of pharmaceuticals and conducting of educational conferences for non-business and/or non-commercial purposes; organizing educational conferences and symposiums in the field of medical science; editing of written text in the nature of medical publications; publication of printed materials and printed publicationsmagazines; newspapersleaflets; publication of texts; all the aforesaid services from Switzerland
Class 42
Scientific research services; medical research; biological research services; clinical research in the field of pharmaceuticals; scientific research and providing information in the fields of biochemistry and biotechnology; genetic research; biological researchclinical research in the field of therapeutics and vaccinesmedical research; product research; laboratory research in the field of pharmaceuticals; technical research in the field of pharmaceutical studies; scientific research; scientific research and development; providing laboratory research services in the field of therapeutics and vaccines; scientific research in the field of biology; information relating to scientific researchscientific research information in the field of pharmaceutical; research in the field of molecular science; scientific research in the field of genetics; product research and development in the field of biotechnology; laboratory research services in the field of dermatology; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; all the aforesaid services from Switzerland
Publications
History of USPTO decisions and trademark events.
39 publications found
C71T
CANCELLED SECTION 71
06/20/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/04/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/10/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/19/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
03/19/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/18/2018
PUBO
PUBLISHED FOR OPPOSITION
09/18/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/15/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/29/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/29/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/29/2018
ALIE
ASSIGNED TO LIE
08/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/23/2018
GNFR
FINAL REFUSAL E-MAILED
04/23/2018
CNFR
FINAL REFUSAL WRITTEN
04/23/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/17/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2018
RFNT
REFUSAL PROCESSED BY IB
10/07/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/18/2017
RFRR
REFUSAL PROCESSED BY MPU
09/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/14/2017
CNRT
NON-FINAL ACTION WRITTEN
09/13/2017
MAFR
APPLICATION FILING RECEIPT MAILED
09/09/2017
DOCK
ASSIGNED TO EXAMINER
09/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/31/2017
Continuous trademark protection
Get notified about every new filing that threatens LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.